Frank Buttacavoli, MD
Orthopaedic Surgery · San Antonio, TXNPI 1487882346
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.6%), speaking fees and education — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Zimmer Biomet at 58.8% of the total. 2025 is the largest year on record at $214,254, 5.0 times the $43,007 reported in 2019. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,049 payments — averaging $825.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$509K
- KCI USA, Inc.$153K
- Sanara Medtech Inc.$87K
- Solventum Corporation$66K
- Medtronic$37K
- Heraeus Medical, LLC.$6K
- plus $9K from 29 others
Across 2 payments — averaging $32,951 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- KCI USA, Inc.$66K
What the payments were for
- Consulting fees$316,79737%
- Speaking & faculty fees$221,73126%
- Travel & lodging$91,36411%
- Food & beverage$25,9003%
- Education$210,01624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 619 | $509,432 |
| KCI USA, Inc. | 136 | $152,708 |
| Sanara Medtech Inc. | 89 | $86,616 |
| Solventum Corporation | 40 | $65,802 |
| Medtronic(2 entities) | 46 | $36,662 |
| Heraeus Medical, LLC. | 11 | $5,838 |
| Restor3d, Inc. | 2 | $2,058 |
| Imbed Biosciences Inc. | 22 | $1,190 |
| Stryker | 9 | $1,034 |
| Davol Inc. | 18 | $499 |
| Smith+Nephew | 6 | $361 |
| Orthalign Inc | 2 | $334 |
| Johnson & Johnson(2 entities) | 3 | $302 |
| Bioventus LLC | 7 | $298 |
| Bone Support Inc. | 2 | $288 |
| Wishbone Medical Inc. | 2 | $233 |
| Heron Therapeutics, Inc. | 6 | $228 |
| Medela LLC | 8 | $220 |
| Kerecis Limited | 1 | $170 |
| Encore Medical, LP | 1 | $167 |
| Si-bone, Inc. | 1 | $160 |
| Globus Medical | 1 | $150 |
| Conformis, Inc. | 2 | $133 |
| Vericel Corporation | 1 | $122 |
| Pacira Pharmaceuticals Incorporated | 2 | $119 |
| Axogen | 1 | $117 |
| Baxter Healthcare | 1 | $115 |
| Medartis Inc. | 1 | $104 |
| Pacira Therapeutics, Inc. | 1 | $103 |
| Acumed LLC | 1 | $97 |
| Vertex | 3 | $93 |
| Acera Surgical, Inc. | 1 | $16 |
| ERMI LLC | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVENA$204,203
- Avenir$201,540
- G7$157,997
- Arcos$117,286
- PREVENA RESTOR ARTHROFORM$106,573
- CellerateRx$82,326
- V.A.C. VERAFLO$78,698
- Avitus Bone Harvester$41,367
- V.A.C. VERAFLO CLEANSE CHOICE$40,704
- NCB$36,975
- AQUAMANTYS$31,828
- Affixus$28,050
- Persona$27,484
- 3M Cavilon$20,060
- Ioban 2$19,665
- Bair Hugger$19,284
- 3M DuraPrep Surgical$18,320
- PREVENA RESTOR AXIOFORM$17,725
- 3M SoluPrep$16,023
- V.A.C. DERMATAC$15,407
How this compares
$865,807 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 30 | $270 |
| Amoxicillin | 27 | $62 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Antonio
- Stephen BurkhartSan Antonio$185.3M
- Michael WirthSan Antonio$4.5M
- Ravi KariaSan Antonio$1.1M
- Charles RockwoodSan Antonio$975K
- Christopher ChaputSan Antonio$959K
- Robert HartzlerSan Antonio$654K
- Bernard MorreySan Antonio$639K
- Animesh AgarwalSan Antonio$408K
- Ralph GarzaSan Antonio$390K
- Anil DuttaSan Antonio$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.